News (51)

Infinant Health Appoints New Team Members to assist with Drug Development PR
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors AQ
MARKER THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
PLIANT THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results GL
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results AQ
PLIANT THERAPEUTICS, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) AQ
Pliant Therapeutics Announces Appointment of Katharine Knobil, M.D. to Board of Directors GL
Pliant Therapeutics Announces Appointment of Katharine Knobil, M.D. to Board of Directors AQ
Pliant Therapeutics Appoints Katharine Knobi to Board of Directors CI
MARKER THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Marker Therapeutics : Reports Fiscal Year 2021 Operating and Financial Results - Form 8-K PU
Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results AQ
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K PU
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) AQ
Arena Pharmaceuticals, Inc. Announces Board Changes CI
Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc.. CI
Transcript : Arena Pharmaceuticals, Inc. - Shareholder/Analyst Call
Marker Therapeutics : Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors - Form 8-K PU
MARKER THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
Marker Therapeutics Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors PR
Marker Therapeutics, Inc. Appoints Katharine Knobil, M.D., to Board of Directors CI
Agilent Technologies Inc. : - Clinical Utility of ALK Fusion Detection by Liquid Biopsy AQ
Agilent Technologies : Clinical Utility of ALK Fusion Detection by Liquid Biopsy BU
ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
Agilent Technologies : Dr. Katharine Knobil Named Agilent's First Chief Medical Officer AQ
Agilent Technologies : Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer BU
Agilent Technologies Inc. Appoints Katharine Knobil as Its Chief Medical Officer CI
KALEIDO BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
Kaleido Biosciences, Inc. Announces Resignation of Katharine Knobil as Chief Medical Officer and Head of Research and Development, Effective as of January 29, 2021 CI
Kaleido Biosciences : Announces Data from MMT Programs Accepted for Presentation at Upcoming Scientific Conferences AQ
Kaleido Biosciences Announces Data from MMT Programs Accepted for Presentation at Upcoming Scientific Conferences GL
Kaleido Biosciences : Announces First Patient Dosed in Clinical Study of Microbiome Metabolic Therapy KB295 in Patients with Mild-to-Moderate Ulcerative Colitis AQ
Kaleido Biosciences Announces First Patient Dosed in Clinical Study of Microbiome Metabolic Therapy KB295 in Patients with Mild-to-Moderate Ulcerative Colitis GL
Kaleido Biosciences Announces Presentation of Data for Microbiome Metabolic Therapy KB174 for Hepatic Encephalopathy at The Digital International Liver Congress™ (EASL) GL
ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) AQ
Kaleido Biosciences Initiates Controlled Clinical Study with Massachusetts General Hospital of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19 GL
ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Arena Pharmaceuticals : Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors PR
Arena Pharmaceuticals Appoints Katharine Knobil to Board of Directors CI
Kaleido Biosciences Initiates Controlled Clinical Study of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19 GL
Kaleido Biosciences to Advance KB174 for Hepatic Encephalopathy Based on Positive Top-Line Results from a Clinical Study in Patients with Cirrhosis GL
Kaleido Biosciences Presents Data from Clinical Study of KB195 in Patients with Urea Cycle Disorders at Society for the Study of Inborn Errors of Metabolism Annual Symposium GL
Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement – Drug Development Summit GL
Cboe Global Markets : Kaleido Biosciences Reports Presented Study, Ex Vivo Data Supporting Microbiome Metabolic Therapy Programs In Diseases Resulting In Hyperammonemia At Int'l. Live Congress PU
12NextSee all

Insiders

Picture Katharine Knobil
Katharine Knobil

Presently, Katharine Knobil occupies the position of Chief Medical Officer of Agilent Technologies, Inc. Dr. Knobil is also on the board of Arena Pharmaceuticals, Inc. and Member of The National Academies of Science. Dr. Knobil previously occupied the position of Chief Medical Officer, Head-Research & Development at Kaleido Biosciences, Inc. and Chief Medical Officer & Senior Vice President at GlaxoSmithKline LLC. Dr. Knobil received an undergraduate degree from Cornell University and a doctorate from The University of Texas Southwestern Medical Center.


Picture Katharine Keenan
Katharine Keenan

Currently, Katharine A. Keenan holds the position of President, Chief Executive Officer & Director at Blackstone Mortgage Trust, Inc. Ms. Keenan is also on the board of Getting Out & Staying Out and Senior MD-Real Estate Debt Strategies at Blackstone, Inc. and Member of Wx, Inc. In her past career she held the position of Vice President at G2 Investment Group LLC and Analyst at Lehman Brothers, Inc. Katharine A. Keenan received an undergraduate degree from Harvard College.


Picture Katharine Stevenson
Katharine Stevenson

Ms. Katharine B. Stevenson is an Independent Director at Capital Power Corp., a Chairman at Canadian Imperial Bank of Commerce, an Independent Director at Open Text Corp. and a Member at Institute of Corporate Directors. She is on the Board of Directors at Capital Power Corp., Open Text Corp., CIBC Bancorp USA, Inc. and St. Michael’s Hospital Foundation. Ms. Stevenson was previously employed as an Independent Director by Valeant Pharmaceuticals International, Inc., a Vice Chairman & Governor by University of Guelph, a Chairman & Treasurer by Financial Executives International Research Foundation, Inc., an Independent Director by CAE, Inc., a Global Treasurer by Nortel Networks Corp., a Vice President-Finance by JPMorgan Chase & Co., and a Governor by The Bishop Strachan School. She also served on the board at OSI Pharmaceuticals, Inc. and Afexa Life Sciences, Inc. She received her undergraduate degree from Harvard University.


Picture Katherine Knobil
Katherine Knobil

Katherine Knobil currently works at ViiV Healthcare Ltd., as Director from 2017.



Picture Katharine Hulls
Katharine Hulls

Katharine Hulls is currently the Vice President-Marketing at Celebrus Technologies Ltd.
She previously worked as a Senior Manager-Marketing at SPSS, Inc., Head-Marketing at Hitwise USA, Inc., Mosaic, Inc., CheetahMail, Inc., and QAS, Inc.


Picture Katharine W. Kenny
Katharine W. Kenny

Katharine W.
Kenny
is currently the Director at Feed More, Inc. She previously worked as the Vice President-Investor Relations at Massey Energy Co. and CarMax, Inc.



Picture Katharine G. Lindemann
Katharine G. Lindemann

Katharine G.
Lindemann
is currently the Director at Cambia Health Solutions, Inc. and Director at IslandWood.
She previously worked as SVP & General Manager-Foodservice at Starbucks Corp., Chief Operating Officer at Flex Pharma, Inc., Senior Vice President-Store Operations at TVI, Inc. (Washington), and Chief Operating Officer at DAVIDsTEA, Inc. She also worked as Principal at KGL Consulting LLC.
Lindemann completed her undergraduate degree from Santa Clara University.




Picture Katharine Maroney
Katharine Maroney

Katharine Maroney is currently a Trustee at Natural Lands Trust, Inc. since 2012.
She was previously a Trustee at Brandywine Conservancy & Museum of Art.


Picture Katharine Dailey
Katharine Dailey

Prior to Joining Perella Weinberg Partners, Ms. Dailey received a Bachelor of Arts in History and Communications from Loyola College in Maryland.


Picture Katharine Winograd
Katharine Winograd

Katharine W.
Winograd
is currently the Chairman of CNM Ingenuity, Inc., Director of Greater Albuquerque Chamber of Commerce, and President of Central New Mexico Community College.
She previously held positions as Director at Presbyterian Healthcare Services and United Way of Central New Mexico, Inc. Winograd received her undergraduate degree from Georgetown College, graduate degree from the University of Louisville, and doctorate from The University of New Mexico.


Picture Katharine J. Rayner
Katharine J. Rayner

Katharine J.
Rayner
currently works at Bryant Park Corp., as Director, Animal Rescue Fund of The Hamptons, Inc., as President & Director, The New York Public Library Astor Lenox & Tilden Foundations, as Trustee, and The Animal Medical Center, as Trustee.




Picture Katharine Anne Wade
Katharine Anne Wade

Katharine Anne Wade is currently a Director at IQUW UK Insurance Group Ltd., ERS Corporate Member Ltd., ERS Administration Services Ltd., and Chief Financial Officer at AEGIS Managing Agency Ltd.
In the past, she worked as the Chief Financial Officer & Director at IQUW Syndicate Management Ltd.
and as a Non-Executive Director at Atlas Corp.
(United Kingdom) from 2021 to 2023.


Picture Katharine Zaleski
Katharine Zaleski

Katharine Zaleski is the founder and current Chairman of PowerToFly, Inc., a company founded in 2014.
She previously held the position of Executive Director-Digital News at Washingtonpost.
Newsweek Interactive and Managing Editor at NowThis Media, Inc. Ms. Zaleski completed her undergraduate degree at Dartmouth College in 2003.


Picture Katharine Cramer
Katharine Cramer

Katharine Cramer is currently working as the Chief Legal & Risk Officer, Executive VP at Premera Blue Cross.
She started this job in 1998 and is currently still employed there.
In terms of education, Ms. Cramer completed her undergraduate and graduate degrees at the University of Washington.
She also obtained a graduate degree from the Washington School of Law.






Picture Katharine Grace Dryer
Katharine Grace Dryer

Katharine Grace Dryer worked at Jupiter Asset Management Ltd.
from 2013 to 2022.
She held the position of Deputy Chief Investment Officer from 2018 to 2022.



Picture Katharine Hatfield
Katharine Hatfield

Katharine D.
Hatfield
currently works at Lift for Life Academy, Inc., as Secretary & Director.


Picture Katharine McLennan
Katharine McLennan

Katharine McLennan worked as a Senior Vice President-People & Culture at Cochlear Ltd.


Picture Katharine Posillico-McGowan
Katharine Posillico-McGowan

Katharine Posillico-McGowan currently works at Family Service League, Inc., as Director & Vice Chairman-Development.




Picture Kathy Eggiman
Kathy Eggiman

Katharine Mary Eggiman is currently working as a Vice President & Relationship Manager at Bell Bank in Fargo, North Dakota.



Picture Katharine C. Golas
Katharine C. Golas

Dr. Katharine C.
Golas
is VP-Training, Simulation & Performance Improvement at Southwest Research Institute.


Picture Kate Huntington
Kate Huntington

Katharine Marshall Huntington is currently a Managing Director at Fiduciary Trust International LLC since 2005.
She previously worked as a Principal at Fiduciary Trust Co., a Research Analyst at Stonebridge Associates LLC, an Economist & Consultant at LECG Corp., a Consulting Associate at Cambridge Associates LLC, and an Economist & Consultant at Capital Economics Ltd.
Ms. Huntington received her undergraduate degree from the University of Virginia in 1997 and her MBA from Yale School of Management in 2005.





Picture Katharine Bolsover
Katharine Bolsover

Katharine Blanche Mary Bolsover is currently the Chairman at TR Property Investment Trust Plc.
She is also a Non-Executive Director at Baillie Gifford & Co. Ltd.
and Bellevue Healthcare Trust Plc.
Previously, she held positions as Chairman at Invesco Enhanced Income Ltd., Fidelity Asian Values Plc, and Tomorrow's People Trust Ltd.
She also served as the Managing Director-Mutual Fund Business at Baring Asset Management Ltd.
and Signature Financial Group, Inc. Additionally, she was the Director-Corporate Communications at JPMorgan Cazenove Holdings Ltd.
and the Managing Director-Mutual Fund Business at Cazenove Group Plc.
Furthermore, she was the Senior Independent Director at Montanaro UK.
Smaller Cos.
Investment Trust Plc and the Independent Non-Executive Director at JPMorgan American Investment Trust Plc.
She also held the position of Managing Director at Baring Fund Managers Ltd.
and was an Independent Non-Executive Director at Global Diversified Infrastructure Plc.
Ms. Bolsover completed her undergraduate and graduate degrees at The University of Exeter.












Picture Katharine Hastie
Katharine Hastie

Katharine Hastie currently works as a Director for the South Carolina Coastal Conservation League, Inc.




Picture Katharine Corbin
Katharine Corbin

Katharine Corbin currently works as a Director at the Arizona Science Center.



Picture Katharine Rachel Sampson
Katharine Rachel Sampson

Katharine Rachel Sampson is currently a Director at Desktop Engineering Ltd., New Technology CADCAM Ltd., Cadtek Systems Ltd., and New Technology 2009 Ltd.
She was previously a Chief Financial Officer & Director at Solid Solutions Management Ltd.


Picture Katharine H. Welling
Katharine H. Welling

Katharine H.
Welling
is currently the Vice Chairman at Spence-Chapin Services to Families & Children.



Picture Katharine Corriveau
Katharine Corriveau

Katharine Corriveau is associated with Instrumentl, Inc. as the founder and holds the title of Chief Operating Officer since 2014.


Picture Katharine Emerson
Katharine Emerson

Katharine Emerson currently works as a Director at the Congressional Hunger Center.





Picture Katharine Jiang
Katharine Jiang

Katharine Jiang currently works as an Associate at UBS Securities Co. Ltd.









Picture Katharine Wianna
Katharine Wianna

Ms. Katharine Wianna is a Director at PT Bola Nusantara and a Director at PT Bali Bintang Sejahtera Tbk.
Ms. Wianna was previously employed as a Marketing Manager by PT Multistrada Arah Sarana Tbk.
She received her undergraduate degree from London School of Public Relations (Jakarta).


Picture Katharine Geldart
Katharine Geldart

Katharine Geldart worked as a Credit Research Associate at Loomis, Sayles & Co. LP from 2016 to 2018.
She then worked as a Senior Research Analyst at Evercore Group LLC from 2018 to 2019.
Geldart received her undergraduate degree from The Isenberg School of Management in 2016.






Picture Katharine Pinfold
Katharine Pinfold

Katharine Pinfold worked as a Secretary & Director at Claremont Ingredients Ltd.



Picture Katharine Ann Hogan
Katharine Ann Hogan

Katharine Ann Hogan currently works at Westbourne House School Educational Trust Ltd., as Member-Governors Board.


Picture Katharine Clark
Katharine Clark

Katharine Clark is an Independent Non-Executive Director at Electrolux Professional AB since 2020.
She previously worked as Vice President-Commercial Development at Assa Abloy AB and as General Manager-EMEA at Chiaro Technology Ltd.
She completed her undergraduate degree from Bournemouth University.









Picture Katharine P. Moir
Katharine P. Moir

Katharine P.
Moir
has worked as a Partner at Latham & Watkins LLP and as a Senior Counsel at Simpson Thacher & Bartlett LLP.


Picture Katharine Spooner
Katharine Spooner

Katharine Spooner worked as an Investment Associate at Sprints Capital Management Ltd.
She graduated from the University of Oxford with a graduate degree in 2018 and from Yale University with an undergraduate degree in 2016.


Picture Katharine Cook
Katharine Cook

Ms. Katharine Cook, CFA, is Senior Portfolio Manager at City National Rochdale LLC.
She joined the firm in September 2013.
She joined the former City National Asset Management (predecessor to City National Rochdale) in 1999 and has over 20 years of experience in financial analysis, planning, and portfolio management.
She specializes in the management of high-net-worth personal, trust, and institutional accounts.
Prior to joining City National, she held similar positions with Sanwa Bank Trust & Investments, Bankers Trust, Wedbush Morgan Securities, IDS Financial Services, and the Los Angeles Times.
Ms. Cook holds a BS in Business Administration from California State University at Los Angeles.
Additionally, she holds the Chartered Financial Analyst designation and is a Certified Financial Planner.
She is an active member of the CFA Institute, the CFA Society of Los Angeles, the Financial Planning Association, and the Social Investment Forum.




Picture Katharine Giles
Katharine Giles

Katharine Giles is currently the Chief Executive Officer, Director & MD at OncoRes Medical Pty Ltd.
She is also an Independent Non-Executive Director at Sonic Healthcare Ltd.
In addition, she holds positions as a Director at Respirion Pharmaceuticals Pty Ltd., an Independent Director at National Reconstruction Fund Corp., and a Venture Partner at Brandon Capital Partners Pty Ltd.
Dr. Giles has an undergraduate degree and an MBA from The University of Western Australia.






Picture Katharine Laud
Katharine Laud

Katharine Laud formerly worked at Provident Financial Services, Inc., as Independent Director from 2011 to 2014, First Morris Bank & Trust, as Director, Provident Bank (Jersey City, New Jersey), as Director from 2007 to 2014, and Homeless Solutions, Inc., as Chief Financial Officer.



No results for this search